Background Statistics & Data Corporation (SDC), a specialized biostatistics and clinical data management contract research organization (CRO), was recently approached by a biotechnology company to discuss a rescue scenario for two pivotal trials running in parallel. Some of the unique challenges associated with this rescue program included: ? An aggressive transition schedule to maintain predetermined study enrollment and randomizatio

Join for free to read